Daryl David Rees

Title: Daryl David Rees: Innovator in Pharmaceutical Chemistry

Introduction

Daryl David Rees, an accomplished inventor based in Godmanchester, GB, has made significant contributions to the field of pharmaceutical chemistry. With a total of four patents to his name, Rees has focused on advancing sterilization methods and chemical compounds that can enhance pharmaceutical formulations.

Latest Patents

Among his notable innovations is the patent for the sterilization of S-nitrosothiols, specifically S-nitrosoglutathione. This invention presents a method for sterilizing S-nitrosothiol that minimizes purity degradation to less than about 5.0%. The innovation allows for the production of sterile S-nitrosothiol or a sterile pharmaceutical pre-composition in dry solid form. This pre-composition can be combined with various diluents, excipients, carriers, and additional active agents, such as sterile saline, facilitating the preparation of a pharmaceutical composition of S-nitrosothiol for therapeutic use.

Career Highlights

Throughout his career, Daryl David Rees has contributed his expertise to several reputable companies, including Phytopharm Plc and Salupont Consulting Ltd. His work in these organizations has played a pivotal role in the development of innovative chemical solutions and pharmaceutical applications.

Collaborations

Rees has collaborated with talented individuals in the field, including Paul Barraclough and Jim Hanson. These collaborations have fostered an environment of creativity and knowledge-sharing, further enhancing the innovation landscape within which he operates.

Conclusion

Daryl David Rees exemplifies the spirit of innovation within the pharmaceutical industry. His groundbreaking patents and collaborative efforts contribute significantly to advancements in pharmaceutical compositions, particularly through his work with S-nitrosothiols. As the field evolves, Rees's inventions will undoubtedly continue to impact the development of effective therapeutic solutions.